156 related articles for article (PubMed ID: 35349303)
41. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.
Le Pichon CE; Meilandt WJ; Dominguez S; Solanoy H; Lin H; Ngu H; Gogineni A; Sengupta Ghosh A; Jiang Z; Lee SH; Maloney J; Gandham VD; Pozniak CD; Wang B; Lee S; Siu M; Patel S; Modrusan Z; Liu X; Rudhard Y; Baca M; Gustafson A; Kaminker J; Carano RAD; Huang EJ; Foreman O; Weimer R; Scearce-Levie K; Lewcock JW
Sci Transl Med; 2017 Aug; 9(403):. PubMed ID: 28814543
[TBL] [Abstract][Full Text] [Related]
42. DLK: the "preconditioning" signal for axon regeneration?
Nix P; Bastiani M
Neuron; 2012 Jun; 74(6):961-3. PubMed ID: 22726825
[TBL] [Abstract][Full Text] [Related]
43. Age-dependent autophagy induction after injury promotes axon regeneration by limiting NOTCH.
Ko SH; Apple EC; Liu Z; Chen L
Autophagy; 2020 Nov; 16(11):2052-2068. PubMed ID: 31920157
[TBL] [Abstract][Full Text] [Related]
44. Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury.
Xiong X; Wang X; Ewanek R; Bhat P; Diantonio A; Collins CA
J Cell Biol; 2010 Oct; 191(1):211-23. PubMed ID: 20921142
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of human insulin gene transcription and MafA transcriptional activity by the dual leucine zipper kinase.
Stahnke MJ; Dickel C; Schröder S; Kaiser D; Blume R; Stein R; Pouponnot C; Oetjen E
Cell Signal; 2014 Sep; 26(9):1792-9. PubMed ID: 24726898
[TBL] [Abstract][Full Text] [Related]
46. Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions.
Ferraris D; Yang Z; Welsbie D
Future Med Chem; 2013 Oct; 5(16):1923-34. PubMed ID: 24175744
[TBL] [Abstract][Full Text] [Related]
47. Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons.
Welsbie DS; Mitchell KL; Jaskula-Ranga V; Sluch VM; Yang Z; Kim J; Buehler E; Patel A; Martin SE; Zhang PW; Ge Y; Duan Y; Fuller J; Kim BJ; Hamed E; Chamling X; Lei L; Fraser IDC; Ronai ZA; Berlinicke CA; Zack DJ
Neuron; 2017 Jun; 94(6):1142-1154.e6. PubMed ID: 28641113
[TBL] [Abstract][Full Text] [Related]
48. A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death.
Waetzig V; Herdegen T
J Biol Chem; 2003 Jan; 278(1):567-72. PubMed ID: 12401814
[TBL] [Abstract][Full Text] [Related]
49. Novel inhibitors of acute, axonal DLK palmitoylation are neuroprotective and avoid the deleterious side effects of cell-wide DLK inhibition.
Zhang X; Jeong H; Niu J; Holland SM; Rotanz BN; Gordon J; Einarson MB; Childers WE; Thomas GM
bioRxiv; 2024 Apr; ():. PubMed ID: 38712276
[TBL] [Abstract][Full Text] [Related]
50. MAPK upstream kinase (MUK)-binding inhibitory protein, a negative regulator of MUK/dual leucine zipper-bearing kinase/leucine zipper protein kinase.
Fukuyama K; Yoshida M; Yamashita A; Deyama T; Baba M; Suzuki A; Mohri H; Ikezawa Z; Nakajima H; Hirai S; Ohno S
J Biol Chem; 2000 Jul; 275(28):21247-54. PubMed ID: 10801814
[TBL] [Abstract][Full Text] [Related]
51. DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury.
Shin JE; Ha H; Kim YK; Cho Y; DiAntonio A
Neurobiol Dis; 2019 Jul; 127():178-192. PubMed ID: 30735704
[TBL] [Abstract][Full Text] [Related]
52. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
53. Tissue transglutaminase triggers oligomerization and activation of dual leucine zipper-bearing kinase in calphostin C-treated cells to facilitate apoptosis.
Robitaille K; Daviau A; Tucholski J; Johnson GV; Rancourt C; Blouin R
Cell Death Differ; 2004 May; 11(5):542-9. PubMed ID: 14739943
[TBL] [Abstract][Full Text] [Related]
54. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration.
Miller BR; Press C; Daniels RW; Sasaki Y; Milbrandt J; DiAntonio A
Nat Neurosci; 2009 Apr; 12(4):387-9. PubMed ID: 19287387
[TBL] [Abstract][Full Text] [Related]
55. Colocalization and Interaction Study of Neuronal JNK3, JIP1, and β-Arrestin2 Together with PSD95.
Musi CA; Marchini G; Giani A; Tomaselli G; Priori EC; Colnaghi L; Borsello T
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456931
[TBL] [Abstract][Full Text] [Related]
56. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
Hu MC; Qiu WR; Wang YP
Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
[TBL] [Abstract][Full Text] [Related]
57. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
[TBL] [Abstract][Full Text] [Related]
58. Guanine-nucleotide exchange protein C3G activates JNK1 by a ras-independent mechanism. JNK1 activation inhibited by kinase negative forms of MLK3 and DLK mixed lineage kinases.
Tanaka S; Hanafusa H
J Biol Chem; 1998 Jan; 273(3):1281-4. PubMed ID: 9430657
[TBL] [Abstract][Full Text] [Related]
59. The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria.
Zhao Y; Spigolon G; Bonny C; Culman J; Vercelli A; Herdegen T
Mol Cell Neurosci; 2012 Mar; 49(3):300-10. PubMed ID: 22206897
[TBL] [Abstract][Full Text] [Related]
60. [Regulation of the JNK signaling pathway by dual leucine zipper kinase DLK.].
Ma XJ; Xue L
Yi Chuan; 2010 Aug; 32(8):785-90. PubMed ID: 20709675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
